Kahn Susan 4
4 · LogicBio Therapeutics, Inc. · Filed Dec 23, 2021
Insider Transaction Report
Form 4
Kahn Susan
Director
Transactions
- Award
Stock Option (right to buy)
2021-12-21+25,000→ 25,000 totalExercise: $2.41Exp: 2031-12-21→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The options were granted pursuant to the Issuer's non-employee director compensation policy in connection with the Reporting Person's appointment as a member of the Issuer's Board of Directors. The options will vest over three years as follows: one third (1/3) of the shares underlying the options will vest on each of the first, second and third anniversaries of the grant date.